← Open Payments lookup

ERIC REYNOLDS: Open Payments

NPI 1710311279 · VERNAL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$560 in 25 payments from 9 companies in 2025. Trend: 2023 $641 · 2024 $603 · 2025 $560

Food & beverage: $560
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$239
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$109
Lundbeck LLC2$46
Novo Nordisk Inc2$41
Gilead Sciences, Inc.1$31
ABBVIE INC.1$26
Axsome Therapeutics, Inc.1$23
Corcept Therapeutics1$23
Verona Pharma, Inc.1$21

Products named: CAPLYTA, FARXIGA, BREZTRI, AIRSUPRA, REXULTI, Wegovy, VRAYLAR, Sunosi.

Industry payments across UT — which companies pay providers there.